| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 3.223 | 7.586 | 7.442 | 7.277 | 6.083 | 7.278 | 108.099 |
| Total Income - EUR | - | - | 0 | 3.225 | 7.591 | 7.442 | 7.277 | 6.087 | 7.278 | 108.103 |
| Total Expenses - EUR | - | - | 617 | 2.418 | 2.322 | 2.300 | 2.220 | 2.236 | 2.648 | 77.344 |
| Gross Profit/Loss - EUR | - | - | -617 | 807 | 5.270 | 5.143 | 5.057 | 3.851 | 4.630 | 30.759 |
| Net Profit/Loss - EUR | - | - | -617 | 711 | 5.042 | 4.930 | 4.844 | 3.678 | 3.963 | 26.576 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
Check the financial reports for the company - Reumaprof Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 18.057 | 15.466 | 12.952 | 10.503 | 8.145 | 6.039 | 3.896 | 5.480 |
| Current Assets | - | - | 77 | 133 | 4.859 | 1.873 | 6.673 | 2.948 | 6.592 | 43.031 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 2.062 | 3.277 |
| Cash | - | - | 77 | 133 | 4.859 | 1.873 | 6.673 | 2.948 | 4.530 | 39.754 |
| Shareholders Funds | - | - | -573 | 148 | 5.187 | 10.019 | 14.641 | 8.978 | 10.277 | 36.795 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 18.707 | 15.451 | 12.623 | 2.357 | 178 | 9 | 211 | 11.715 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Reumaprof Srl